A detailed history of Baird Financial Group, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Baird Financial Group, Inc. holds 227,726 shares of BAX stock, worth $7.56 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
227,726
Previous 255,789 10.97%
Holding current value
$7.56 Million
Previous $8.56 Million 1.05%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$32.85 - $40.26 $921,869 - $1.13 Million
-28,063 Reduced 10.97%
227,726 $8.65 Million
Q2 2024

Aug 13, 2024

BUY
$32.87 - $43.55 $720,609 - $954,746
21,923 Added 9.37%
255,789 $8.56 Million
Q1 2024

May 14, 2024

BUY
$37.88 - $43.77 $2.17 Million - $2.51 Million
57,402 Added 32.53%
233,866 $10 Million
Q4 2023

Feb 14, 2024

BUY
$31.71 - $38.95 $2.55 Million - $3.14 Million
80,514 Added 83.91%
176,464 $6.82 Million
Q3 2023

Nov 13, 2023

BUY
$37.32 - $49.29 $44,597 - $58,901
1,195 Added 1.26%
95,950 $3.62 Million
Q2 2023

Aug 11, 2023

SELL
$39.98 - $47.68 $4.59 Million - $5.47 Million
-114,707 Reduced 54.76%
94,755 $4.32 Million
Q1 2023

May 15, 2023

BUY
$37.58 - $52.57 $317,701 - $444,426
8,454 Added 4.21%
209,462 $8.5 Million
Q3 2022

Nov 14, 2022

SELL
$53.86 - $66.8 $126,355 - $156,712
-2,346 Reduced 0.87%
265,850 $14.3 Million
Q2 2022

Aug 08, 2022

SELL
$63.83 - $80.0 $582,576 - $730,160
-9,127 Reduced 3.29%
268,196 $17.2 Million
Q1 2022

May 13, 2022

BUY
$76.85 - $89.45 $748,442 - $871,153
9,739 Added 3.64%
277,323 $21.5 Million
Q4 2021

Feb 09, 2022

SELL
$74.57 - $87.19 $38,925 - $45,513
-522 Reduced 0.19%
267,584 $23 Million
Q3 2021

Nov 12, 2021

BUY
$73.77 - $83.61 $741,167 - $840,029
10,047 Added 3.89%
268,106 $21.6 Million
Q2 2021

Aug 11, 2021

BUY
$80.5 - $88.01 $724 - $792
9 Added 0.0%
258,059 $20.8 Million
Q1 2021

May 13, 2021

BUY
$76.38 - $86.03 $822,994 - $926,973
10,775 Added 4.36%
258,050 $21.8 Million
Q4 2020

Feb 11, 2021

SELL
$75.39 - $82.36 $405,673 - $443,179
-5,381 Reduced 2.13%
247,275 $19.8 Million
Q3 2020

Nov 12, 2020

BUY
$78.33 - $90.73 $4.12 Million - $4.77 Million
52,551 Added 26.26%
252,656 $20.3 Million
Q2 2020

Oct 22, 2020

BUY
$78.66 - $94.14 $5.75 Million - $6.88 Million
73,053 Added 57.5%
200,105 $17.2 Million
Q2 2020

Aug 14, 2020

SELL
$78.66 - $94.14 $729,256 - $872,771
-9,271 Reduced 6.8%
127,052 $10.6 Million
Q1 2020

May 14, 2020

SELL
$71.57 - $93.3 $1.73 Million - $2.26 Million
-24,240 Reduced 15.1%
136,323 $11.1 Million
Q4 2019

Feb 14, 2020

SELL
$76.7 - $88.45 $1.25 Million - $1.44 Million
-16,312 Reduced 9.22%
160,563 $13.4 Million
Q3 2019

Nov 14, 2019

SELL
$81.4 - $89.78 $7,163 - $7,900
-88 Reduced 0.05%
176,875 $15.5 Million
Q2 2019

Aug 14, 2019

BUY
$73.44 - $82.41 $1.69 Million - $1.9 Million
23,023 Added 14.96%
176,963 $14.5 Million
Q1 2019

May 14, 2019

BUY
$64.48 - $81.31 $1.56 Million - $1.97 Million
24,229 Added 18.68%
153,940 $12.5 Million
Q4 2018

Feb 14, 2019

BUY
$61.45 - $77.8 $1.61 Million - $2.04 Million
26,244 Added 25.36%
129,711 $8.54 Million
Q3 2018

Nov 13, 2018

BUY
$70.71 - $77.75 $598,065 - $657,609
8,458 Added 8.9%
103,467 $8.05 Million
Q2 2018

Aug 13, 2018

SELL
$63.43 - $75.41 $112,144 - $133,324
-1,768 Reduced 1.83%
95,009 $7.01 Million
Q1 2018

May 14, 2018

SELL
$62.56 - $72.26 $1.06 Million - $1.22 Million
-16,904 Reduced 14.87%
96,777 $6.29 Million
Q4 2017

Feb 09, 2018

BUY
$61.45 - $66.05 $58,500 - $62,879
952 Added 0.84%
113,681 $7.35 Million
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $31,178 - $33,855
524 Added 0.47%
112,729 $7.07 Million
Q2 2017

Aug 14, 2017

BUY
N/A
112,205
112,205 $6.79 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.